Abbott India Q1 Results FY27: Uniresearch Prediction and Analysis
- June 25, 2026
- Posted by: Kunal Singla
- Category: News
Abbott India Q1 Results FY27: Uniresearch projects Revenue Rs 1,939 Cr | PAT Rs 408 Cr (Uniresearch trailing analysis). Q4 FY26: Rev Rs 1,710 Cr | PAT Rs 395 Cr.
Abbott India Q1 Results FY27 outlook from Uniresearch is anchored on verified Q4 FY26 actuals and Uniresearch trailing analysis. Uniresearch projects Abbott India Q1 FY27 Revenue Rs 1,939 Cr (+11.6% YoY) and PAT Rs 408 Cr (+11.6% YoY). Prepared by Ankit Jaiswal.
Click Here – Get Free Investment Predictions
Abbott India Q1 Results FY27 – Uniresearch Prediction
| Metric | Q1 FY26 Actual | Q1 FY27 Uniresearch Prediction | YoY Change | Source |
|---|---|---|---|---|
| Abbott India Revenue (Rs Cr) | 1,738 | 1,939 | +11.6% | Uniresearch | Uniresearch trailing analysis |
| PAT (Rs Cr) | 366 | 408 | +11.6% | Uniresearch | Uniresearch trailing analysis |
| Avg Analyst Target | See screener | 12-month view | – | Uniresearch trailing analysis |
Abbott India Q4 FY26 Performance
| Metric | Q4 FY26 Actual | vs Q1 FY26 | Source |
|---|---|---|---|
| Revenue (Rs Cr) | 1,710 | -1.6% | Screener consolidated |
| PAT (Rs Cr) | 395 | +7.9% | Screener consolidated |
Analyst Views and Growth Outlook
The Uniresearch trailing analysis projects Abbott India FY27 revenue at +11.6% and profit at +11.6% YoY. Uniresearch applied these growth rates to Q1 FY26 actuals to derive the Q1 FY27 prediction. Q4 FY26 actuals showed Abbott India delivering revenue of Rs 1,710 Cr and PAT of Rs 395 Cr.
Key Watchpoints
Revenue Delivery
Key question: can Abbott India reach Rs 1,939 Cr in Q1 FY27 revenue, representing +11.6% YoY growth over the Q1 FY26 base of Rs 1,738 Cr.
PAT vs Growth Target
Profit performance of Rs 408 Cr (+11.6%) vs the Q1 FY26 base of Rs 366 Cr is the profitability watchpoint for Abbott India in Q1 FY27.
Risks
Revenue Shortfall
Revenue below the +11.6% consensus would indicate sector headwinds or execution delays for Abbott India.
Margin Pressure
Cost increases or margin compression could challenge the +11.6% PAT growth projection for Abbott India in Q1 FY27.
Conclusion
The Abbott India Q1 FY27 Uniresearch projection of Revenue Rs 1,939 Cr and PAT Rs 408 Cr is derived from the Uniresearch trailing analysis. Investors should watch Q4 FY26 actuals as the base, and track Abbott India live on the Univest Screener.
Track Abbott India Live on the Univest Screener
Download the Univest iOS App or Univest Android App for live FY27 alerts.
Disclaimer: Revenue and PAT actuals are sourced from consolidated quarterly financial data. Q1 Results FY27 Uniresearch predictions are derived by applying analyst consensus growth rates to verified Q1 FY26 actuals. These are projections, not guaranteed outcomes. Investments in securities are subject to market risk. For educational purposes only. SEBI RA INH000013776.
FAQs on Abbott India Q1 Results FY27
What is Uniresearch’s PAT prediction for Abbott India Q1 Results FY27?
Ans. Uniresearch projects Abbott India Q1 FY27 PAT at Rs 408 Cr (+11.6% vs Q1 FY26 base Rs 366 Cr).
What is the Revenue forecast for Abbott India Q1 Results FY27?
Ans. Abbott India Q1 FY27 Revenue is projected at Rs 1,939 Cr (+11.6% consensus).
What were Abbott India Q4 FY26 actuals for Abbott India Q1 Results FY27?
Ans. Q4 FY26 Revenue Rs 1,710 Cr and PAT Rs 395 Cr.
How many analysts cover Abbott India Q1 Results FY27?
Ans. The prediction uses Uniresearch trailing analysis, avg target Rs 0.
What consensus applies to Abbott India Q1 Results FY27?
Ans. Revenue +11.6% and profit +11.6% (Uniresearch trailing analysis).
What are the main risks to Abbott India Q1 Results FY27?
Ans. Revenue missing +11.6% consensus and PAT pressure vs +11.6% growth target.
What is the Q1 FY26 base for Abbott India Q1 Results FY27?
Ans. Q1 FY26 Revenue Rs 1,738 Cr and PAT Rs 366 Cr.
